Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Savage

Showing results (181-190 of 227) with videos related to

Pageof 23
Sort By:
Nature|November 30, 2007
Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1Coenraad Kuijl, Nigel D L Savage, Marije Marsman, et al.
Cell|August 11, 2021
Whole-body integration of gene expression and single-cell morphologyHernando M Vergara, Constantin Pape, Kimberly I Meechan, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2017
Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignanciesStephen E Kurtz, Christopher A Eide, Andy Kaempf, et al.
Bioorganic & Medicinal Chemistry|July 28, 2006
Discovery of potent, selective 4-fluoroproline-based thrombin inhibitors with improved metabolic stabilityDonnette D Staas, Kelly L Savage, Vanessa L Sherman, et al.
Investigational New Drugs|January 6, 2021
NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemiaRenata Scopim-Ribeiro, João Agostinho Machado-Neto, Christopher A Eide, et al.
The Review of Scientific Instruments|December 3, 2016
The Advanced LIGO photon calibratorsS Karki, D Tuyenbayev, S Kandhasamy, et al.
Cancer Cell|September 24, 2019
Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 MutantsChristopher A Eide, Matthew S Zabriskie, Samantha L Savage Stevens, et al.
The Lancet. Neurology|March 5, 2013
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial, K E Morrison, S Dhariwal, et al.
Nature|October 19, 2018
Functional genomic landscape of acute myeloid leukaemiaJeffrey W Tyner, Cristina E Tognon, Daniel Bottomly, et al.
Cancer Cell|July 22, 2022
Integrative analysis of drug response and clinical outcome in acute myeloid leukemiaDaniel Bottomly, Nicola Long, Anna Reister Schultz, et al.
Pageof 23

Showing results (181-190 of 227) with videos related to

Sort By:
Pageof 23
Nature|November 30, 2007
Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1Coenraad Kuijl, Nigel D L Savage, Marije Marsman, et al.
Cell|August 11, 2021
Whole-body integration of gene expression and single-cell morphologyHernando M Vergara, Constantin Pape, Kimberly I Meechan, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2017
Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignanciesStephen E Kurtz, Christopher A Eide, Andy Kaempf, et al.
Bioorganic & Medicinal Chemistry|July 28, 2006
Discovery of potent, selective 4-fluoroproline-based thrombin inhibitors with improved metabolic stabilityDonnette D Staas, Kelly L Savage, Vanessa L Sherman, et al.
Investigational New Drugs|January 6, 2021
NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemiaRenata Scopim-Ribeiro, João Agostinho Machado-Neto, Christopher A Eide, et al.
The Review of Scientific Instruments|December 3, 2016
The Advanced LIGO photon calibratorsS Karki, D Tuyenbayev, S Kandhasamy, et al.
Cancer Cell|September 24, 2019
Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 MutantsChristopher A Eide, Matthew S Zabriskie, Samantha L Savage Stevens, et al.
The Lancet. Neurology|March 5, 2013
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial, K E Morrison, S Dhariwal, et al.
Nature|October 19, 2018
Functional genomic landscape of acute myeloid leukaemiaJeffrey W Tyner, Cristina E Tognon, Daniel Bottomly, et al.
Cancer Cell|July 22, 2022
Integrative analysis of drug response and clinical outcome in acute myeloid leukemiaDaniel Bottomly, Nicola Long, Anna Reister Schultz, et al.
Pageof 23